RedHill Biopharma (RDHL) Completes pre-IND Meeting for RHB-104 Phase III; Offers Progress Update
RedHill Biopharma (Nasdaq: RDHL) provided an update on the progress with the ongoing RHB-104 Phase III development program for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)